- Pressemitteilung BoxID 518972
IADR/Straumann Award in Regenerative Periodontal Medicine presented to Anton Sculean
The objective of the Award is to recognize significant contributions in basic and/or clinical research in regenerative periodontal or peri-implant medicine. The 2012 Award was presented by Prof. Alpdogan Kantarci, President of the IADR Periodontal Research Group, and Prof. Michel Dard, Head of Preclinical Research at Straumann.
"Prof. Sculean has contributed significantly to our understanding of oral tissue regeneration throughout his career", noted Prof. Alpdogan Kantarci. "As a preclinical and clinical investigator, he has evaluated all major approaches to periodontal regeneration. Furthermore, he has been an outstanding educator, a respected leader and a strong advocate of evidence-based regenerative medicine. In view of his continued active involvement and impressive output over the past 10 years the PRG board was unanimous in its decision to nominate him for this highly prestigious award", he added.
Worth a total of USD 5000, the IADR/Straumann Award in Regenerative Periodontal Medicine is sponsored by Straumann and administered by the Periodontal Research Group of the IADR. Straumann is a leading contributor to R&D in implant and regenerative dentistry and this award is a further example of the Group's commitment to fostering and recognizing excellence in dental research.
About the International Association for Dental Research
Based in Alexandria, Va., USA, the International Association for Dental Research (IADR) is a nonprofit organization with more than 12 000 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge to improve oral health, (2) supporting the oral health research community, and (3) facilitating the communication and application of research findings for the improvement of oral health worldwide. For more information on the IADR, see www.iadr.org. Within the IADR, the Periodontal Research Group is the forum for members who are active in periodontology. Its aim is to improve periodontal health through encouraging research activities.
Über Institut Straumann AG
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately 2450 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.
Diese Pressemitteilungen könnten Sie auch interessieren
Für Markeninhaber wird wegen der Einführung von mehr als 1000 neuen Top Level Domains die Anmeldung im neu geschaffenen Trademark Clearinghouse sinnvoll. Markeninhaber,...
Turnusgemäß haben die Loewe Fachhandelspartner den Loewe Handelssenat gewählt. In das Gremium, das die Interessen des Handels gegenüber Loewe vertritt und das Unternehmen...
. - Stefan Winners neuer Aufsichtsratsvorsitzender - Anette Weber Finanzexpertin im Aufsichtsrat Die Hauptversammlung der Hamburger XING AG (ISIN DE000XNG8888)...